Loading
Latest filing published 30 Aug 2021 for Kindred Biosciences, Inc., €619k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Wendy Wee in Kindred Biosciences, Inc., where the filings describe the role as finance chief. Over a trading history stretching from 23 January 2018 to 27 August 2021, the count stands at 13 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 30 August 2021 with a transaction (€619k) in Kindred Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration